3636 — Mitsubishi Research Institute Balance Sheet
0.000.00%
- ¥77bn
- ¥52bn
- ¥115bn
- 94
- 77
- 78
- 97
Annual balance sheet for Mitsubishi Research Institute, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 32,738 | 29,397 | 33,157 | 25,226 | 30,927 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 13,596 | 17,734 | 38,074 | 42,775 | 40,577 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 56,028 | 59,142 | 73,921 | 71,154 | 74,282 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 10,625 | 11,310 | 10,659 | 12,114 | 10,937 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 96,253 | 99,704 | 114,652 | 118,009 | 119,732 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 19,228 | 20,618 | 30,239 | 30,777 | 31,128 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 42,395 | 43,425 | 51,600 | 52,208 | 52,101 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 53,858 | 56,279 | 63,052 | 65,801 | 67,631 |
| Total Liabilities & Shareholders' Equity | 96,253 | 99,704 | 114,652 | 118,009 | 119,732 |
| Total Common Shares Outstanding |